Digital Cognitive Rehabilitation for Sickle Cell Disease
(ALL IN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called Cogmed+, which combines digital memory training and social support to help children with sickle cell disease improve their working memory. The trial aims to determine if this approach is practical and can be used daily by patients. Children and teens, ages 7-16, who have sickle cell disease and struggle with memory tasks may be suitable for this study. As an unphased trial, it offers a unique opportunity to explore innovative ways to enhance memory in young patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you recently started or changed the dose of a stimulant medication for attention problems, you might not be eligible to participate.
What prior data suggests that this digital cognitive rehabilitation is safe for youth with sickle cell disease?
Research on digital cognitive rehabilitation tools like Cogmed+ lacks specific safety data for humans. However, tests have assessed its usability and user satisfaction. Cogmed+ aims to improve memory skills through digital exercises. As it doesn't involve medication, it is generally considered safe and easy to use. No reports of harmful side effects have emerged, which is encouraging for potential trial participants.12345
Why are researchers excited about this trial?
Unlike the standard of care for cognitive issues in sickle cell disease, which often includes medications and cognitive therapy, Cogmed+ offers a digital approach. This treatment is unique because it provides home-based cognitive rehabilitation and memory strategy training specifically targeting working memory. Researchers are excited about Cogmed+ because it allows patients to engage with their treatment in the comfort of their own homes and is tailored to improve specific cognitive functions impacted by sickle cell disease. By utilizing a digital platform, it could offer more flexibility and accessibility than traditional methods.
What evidence suggests that this digital cognitive rehabilitation is effective for sickle cell disease?
Research has shown that Cogmed, a digital training program, may improve memory in young people with sickle cell disease (SCD). This trial will evaluate Cogmed+, an enhanced version of the program, as a home-based digital cognitive rehabilitation and memory strategy training targeting working memory functioning. Studies have examined the ease of use of Cogmed at home for children with SCD. Early results suggest that Cogmed can enhance memory skills, which are often challenging for these children. The program aims to improve daily life by training the brain to better hold and manage information, which is particularly useful for boosting attention and memory in young people with SCD.16789
Who Is on the Research Team?
Steven Hardy, PhD
Principal Investigator
Children's National Research Institute
Are You a Good Fit for This Trial?
This trial is for young people aged 7-16 with sickle cell disease who have working memory challenges. They must be able to use a computer and speak English well, without recent changes in attention disorder medication or mental health conditions that would interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in Cogmed+ program, including digital cognitive rehabilitation and memory strategy training, with weekly videoconference coaching
Follow-up
Participants are monitored for adherence and effectiveness of the Cogmed+ program
What Are the Treatments Tested in This Trial?
Interventions
- Cogmed+
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's National Research Institute
Lead Sponsor